Roper St. Francis Healthcare Receives OK to Trial Cancer Drug with COVID-19 Patients

Hospitalized COVID-19 patients at Roper St. Francis Healthcare soon will have the opportunity to be treated with a drug typically used to fight cancer.

Roper St. Francis Healthcare was approved Thursday to begin treating COVID-19 patients with the drug selinexor, making it the only site in South Carolina, one of only 19 sites nationwide and 42 sites internationally at this time that are participating in the study.

“We have established that we have a cutting-edge team of specialists who are providing excellent care for our COVID-19 patients, we are actively involved in clinical research, and we can move efficiently to activate a trial and enroll patients within a few days,” said Dr. George Geils Jr., a hematologist/oncologist at RSFH  and principal investigator for the trial.

Read the full article, HERE.